Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ReCOUP: Upadacitinib Re-induction in Ulcerative Colitis
NCT07700446Phase 4Not yet recruiting
- Sponsor
- GETAID
- Start
- Nov 2026
- Primary completion
- Nov 2029
01
Overview
A Phase 4 trial of upadacitinib in ulcerative colitis (UC), sponsored by GETAID. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
upadacitinib
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT07700446.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07700446.